GUIDED THERAPEUTICS, INC.
Income Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $244.0K | $0 | $42.0K | $65.0K | $820.0K | $3.3M | $3.6M | $3.4M |
| Cost of Revenue | $530.0K | $493.0K | $537.0K | $891.0K | $611.0K | $117.0K | $-106.0K | $0 |
| Gross Profit | $-286.0K | $112.0K | $27.0K | $-133.0K | $-252.0K | $-45.0K | $-81.0K | $3.4M |
| Gross Margin | -117.2% | — | 64.3% | -204.6% | -30.7% | -1.3% | -2.3% | 100.0% |
| Operating Expenses | ||||||||
| Research & Development | $334.0K | $733.0K | $1.5M | $2.8M | $2.7M | $3.2M | $2.8M | $1.8M |
| SG&A Expense | $2.3M | $2.8M | $4.1M | $4.6M | $3.5M | $3.9M | $3.6M | $3.0M |
| Operating Income | $-3.1M | $-3.8M | $-6.2M | $-8.7M | $-6.6M | $-4.3M | $-6.8M | $-1.6M |
| Operating Margin | -1,279.1% | — | -14,826.2% | -13,336.9% | -805.6% | -128.3% | -187.8% | -48.2% |
| Interest Expense | $1.1M | $1.9M | $1.3M | $979.0K | $45.0K | $72.0K | $80.0K | $1.2M |
| Pretax Income | $-10.7M | $-4.0M | $-6.9M | — | — | — | — | — |
| Income Tax Expense | $0 | $0 | — | — | — | — | — | — |
| Net Income | $-10.7M | $-4.0M | $-6.9M | $-9.9M | $-7.2M | $-4.4M | $-6.6M | $-2.8M |
| Net Margin | -4,383.6% | — | -16,433.3% | -15,204.6% | -879.9% | -130.4% | -184.7% | -84.6% |
| EPS (Basic) | $0.13 | $0.00 | $-0.80 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| EPS (Diluted) | $0.00 | $0.00 | $-0.80 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Shares Outstanding (Basic) | 63.2M | 1.5M | 9.5M | 5.7M | 491.0M | 428.0M | 364.2M | 287.6M |
| Shares Outstanding (Diluted) | 0 | 1.5M | 9.5M | 5.7M | 491.0M | 428.0M | 364.2M | 287.6M |
| Dividends Per Share | — | — | — | — | — | — | — | — |